Cargando…

Correction: High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453612/ https://www.ncbi.nlm.nih.gov/pubmed/28570697 http://dx.doi.org/10.1371/journal.pone.0179139

Ejemplares similares

High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
por: Honda, Hirokazu, et al.
Publicado: (2017)

Fibroblast growth factor-23 levels in maintenance hemodialysis patients in India
por: Anandh, U., et al.
Publicado: (2017)

Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis
por: Nishizawa, Yoko, et al.
Publicado: (2020)

INCREASING AND DECREASING PHASES OF FERRITIN AND HEMOSIDERIN IRON DETERMINED BY SERUM FERRITIN KINETICS
por: SAITO, HIROSHI, et al.
Publicado: (2013)

Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
por: Shima, Hisato, et al.
Publicado: (2018)

Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation
por: Kawabata, Chiaki, et al.
Publicado: (2019)

Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders
por: Takasawa, Kazuya, et al.
Publicado: (2018)

High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis
por: Fang, Yu-Wei, et al.
Publicado: (2023)

Correction: Iron deficiency associates with deterioration in several symptoms independently from hemoglobin level among chronic hemodialysis patients
por: Motonishi, Shuta, et al.
Publicado: (2018)

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Kawai, Masanobu, et al.
Publicado: (2020)

Intravenous Phosphate Loading Increases Fibroblast Growth Factor 23 in Uremic Rats
por: Arai-Nunota, Noriko, et al.
Publicado: (2014)

Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients
por: Zheng, Shubei, et al.
Publicado: (2018)

Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
por: Roberts, Matthew A., et al.
Publicado: (2016)

Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2013)

Author Correction: Biofortification of field-grown cassava by engineering expression of an iron transporter and ferritin
por: Narayanan, Narayanan, et al.
Publicado: (2019)

Author Correction: The relationship between plasma ferritin levels and body mass index among adolescents
por: Shattnawi, Khulood K., et al.
Publicado: (2019)

Blood Transfusion, Serum Ferritin, and Iron in Hemodialysis Patients in Africa
por: Kouegnigan Rerambiah, Leonard, et al.
Publicado: (2015)

Iron and Ferritin Levels in Saliva of Patients with Thalassemia and Iron Deficiency Anemia
por: Canatan, Duran, et al.
Publicado: (2012)

Correction: L-Ferritin Binding to Scara5: A New Iron Traffic Pathway Potentially Implicated in Retinopathy
por: Mendes-Jorge, Luísa, et al.
Publicado: (2017)

Correction to: Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
Publicado: (2020)

Correction: The Relationship between Serum Ferritin Levels and Insulin Resistance in Pre- and Postmenopausal Korean Women: KNHANES 2007-2010
por: Kim, Min Kyoung, et al.
Publicado: (2016)

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients
por: Jalalzadeh, M., et al.
Publicado: (2012)

Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients
por: Lee, Wen-Teng, et al.
Publicado: (2023)

ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation
por: Park, Eunhee, et al.
Publicado: (2019)

Multisystem Inflammatory Syndrome in an Adult on Hemodialysis with Markedly Elevated Procalcitonin and Ferritin Levels
por: Asano, Shuichi, et al.
Publicado: (2023)

Serum iron level, ferritin and total iron binding capacity level among nonpregnant women with and without melasma
por: Behrangi, Elham, et al.
Publicado: (2015)

Correction: The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials
por: Zittermann, Armin, et al.
Publicado: (2021)

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
por: Peters, N. O., et al.
Publicado: (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Changes of Hepcidin, Ferritin and Iron Levels in Cycling Purebred Spanish Mares
por: Satué, Katiuska, et al.
Publicado: (2023)

Correction: Iron Supplementation Decreases Severity of Allergic Inflammation in Murine Lung
por: Hale, Laura P., et al.
Publicado: (2014)

Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. Int. J. Mol. Sci. 2022, 23, 2140
por: Funk, Felix, et al.
Publicado: (2022)

Correction to: High-dose opioid utilization and mortality among individuals initiating hemodialysis
por: Daubresse, Matthew, et al.
Publicado: (2021)

Iron status and fibroblast growth factor-23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2012)

Author Correction: An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
por: Theerajangkhaphichai, Wasan, et al.
Publicado: (2023)

Options for intravenous iron supplementation in hemodialysis patients
por: Kong, Ji Yoon, et al.
Publicado: (2020)

Correction: Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
por: Pichler, Irene, et al.
Publicado: (2013)

Urine fibroblast growth factor 23 levels in hypertensive children and adolescents
por: Zając, Magdalena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ke6g7b44dlc9d3mnvm6camdi3t